+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID05560958

Post-market Follow-up Study of BIOTRONIK Electrophysiology Products Used in Cardiac Arrhythmia Procedures

Led by Biotronik SE & Co. KG · Updated on 2026-09-08

280

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are collecting data to evaluate the safety, performance, and clinical benefits of BIOTRONIKs electrophysiology EP products used in patients with cardiac arrhythmias. This observational, multi-center, international study aims to fulfill regulatory requirements and maintain approval of these devices in the CE region by monitoring any residual or newly emerging risks associated with their use. Participants in the study undergo routine diagnostic or therapeutic catheter interventions involving BIOTRONIK EP products, including catheters AlCath, MultiCath, ViaCath, external devices Qubic RF, Qubic Stim, Qiona, and transseptal sheaths Senovo Bi-Flex. These devices are applied temporarily during electrophysiology studies or catheter ablation procedures and used together with external equipment like RF generators, pacemakers, and irrigation pumps. During the study, participants data from these procedures and follow-ups will be collected to assess device deficiencies, adverse effects during and after procedures up to 3 to 6 months, and confirmations of clinical benefits at the time of procedure. Follow-up visits are required at the study sites to monitor safety and device performance over time, with the study expected to continue until July 2030.

CONDITIONS

Brief Title

Post-market Clinical Follow-up Data Collection From Procedures With BIOTRONIK EP Products

Research Team

A

Annette Thiem, Dr.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here